IRIS Accounts Production v25.1.3.33 05392001 Board of Directors 31.3.23 29.9.24 29.9.24 0 0 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh053920012023-03-30053920012024-09-29053920012023-03-312024-09-29053920012022-03-30053920012022-03-312023-03-30053920012023-03-3005392001ns15:EnglandWales2023-03-312024-09-2905392001ns14:PoundSterling2023-03-312024-09-2905392001ns10:Director12023-03-312024-09-2905392001ns10:PrivateLimitedCompanyLtd2023-03-312024-09-2905392001ns10:SmallEntities2023-03-312024-09-2905392001ns10:AuditExempt-NoAccountantsReport2023-03-312024-09-2905392001ns10:SmallCompaniesRegimeForDirectorsReport2023-03-312024-09-2905392001ns10:SmallCompaniesRegimeForAccounts2023-03-312024-09-2905392001ns10:FullAccounts2023-03-312024-09-2905392001ns10:Director22023-03-312024-09-2905392001ns10:CompanySecretary12023-03-312024-09-2905392001ns10:RegisteredOffice2023-03-312024-09-2905392001ns5:CurrentFinancialInstruments2024-09-2905392001ns5:CurrentFinancialInstruments2023-03-3005392001ns5:ShareCapital2024-09-2905392001ns5:ShareCapital2023-03-3005392001ns5:RetainedEarningsAccumulatedLosses2024-09-2905392001ns5:RetainedEarningsAccumulatedLosses2023-03-3005392001ns5:CostValuation2023-03-3005392001ns5:CostValuation2024-09-2905392001ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-2905392001ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3005392001ns5:Non-currentFinancialInstruments2024-09-2905392001ns5:Non-currentFinancialInstruments2023-03-30
REGISTERED NUMBER: 05392001 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

31 MARCH 2023 TO 29 SEPTEMBER 2024

FOR

RICHARD'S PHARMA LIMITED

RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)






CONTENTS OF THE FINANCIAL STATEMENTS
for the period 31 March 2023 to 29 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


RICHARD'S PHARMA LIMITED

COMPANY INFORMATION
for the period 31 March 2023 to 29 September 2024







DIRECTORS: Mrs S E Taylor
L D Taylor





SECRETARY: L D Taylor





REGISTERED OFFICE: Unit 2
Bosworth Avenue
Tournament Fields
Warwick
Warwickshire
CV34 6UQ





REGISTERED NUMBER: 05392001 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB

RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

BALANCE SHEET
29 September 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Investments 4 110,653 110,653

CURRENT ASSETS
Debtors 5 11,558,640 9,488,547
Cash at bank 194,528 585,352
11,753,168 10,073,899
CREDITORS
Amounts falling due within one year 6 5,731,183 4,772,892
NET CURRENT ASSETS 6,021,985 5,301,007
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,132,638

5,411,660

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 6,132,538 5,411,560
SHAREHOLDERS' FUNDS 6,132,638 5,411,660

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 29 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 29 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 June 2025 and were signed on its behalf by:





L D Taylor - Director


RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

NOTES TO THE FINANCIAL STATEMENTS
for the period 31 March 2023 to 29 September 2024

1. STATUTORY INFORMATION

Richard's Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investments in subsidiaries and associates
Investments in subsidiary and associate undertakings are recognised at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - NIL).

RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 31 March 2023 to 29 September 2024

4. FIXED ASSET INVESTMENTS
Shares in Interest
group in
undertakings associate Totals
£    £    £   
COST
At 31 March 2023
and 29 September 2024 97,653 13,000 110,653
NET BOOK VALUE
At 29 September 2024 97,653 13,000 110,653
At 30 March 2023 97,653 13,000 110,653

5. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 248,516 (1,151 )
Amounts owed by group undertakings 4,479,848 2,452,176
Other debtors 2,187,216 341,216
VAT 11,288 14,306
Prepayments and accrued income 131,772 182,000
7,058,640 2,988,547

Amounts falling due after more than one year:
Amounts owed by group undertakings 4,500,000 4,500,000
Other debtors - 2,000,000
4,500,000 6,500,000

Aggregate amounts 11,558,640 9,488,547

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 262,393 12,867
Other creditors 3,738,000 2,503,381
Directors' current accounts 1,562,934 1,177,894
Directors' loan accounts - 950,000
Accrued expenses 167,856 128,750
5,731,183 4,772,892

7. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Richard's Pharma (Holdings) Limited.